Procedures & recovery · patient guide

Cancer Staging Review in China: The Role of Previous Treatment Results

Describe previous treatment by pairing each treatment name with its measurable result: what was given, when, how the disease responded, and what imaging or pathology showed. A list of drug or operation names alone cannot show disease extent or response. For a staging review in China, provide dated reports and images so the treating team can assess what remains uncertain.

Go to the practical guidance ↓
Editorial illustration: Cancer Staging Review in China: The Role of Previous Treatment Results
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Why a treatment name is not a result

A treatment name tells a clinician what was attempted. It does not tell them what happened to the disease. Two patients can both write 'chemotherapy' and 'surgery', yet one may have had a complete imaging response while the other progressed during treatment. Those are different clinical situations, and they can lead to different discussions about further assessment and treatment.

Cancer stage describes the extent of disease. Staging approaches differ between cancer types, and the stage helps inform treatment discussions. Previous treatment can change what imaging and pathology show, so a review needs the result of that treatment, not only its label. That is why a staging review in China depends on the record of response, not a recital of drug names.

When you send a summary, the useful unit is a treatment episode with an outcome. For example: 'Carboplatin and pemetrexed, six cycles, completed in March; post-treatment CT showed reduction in the primary lung lesion and no new lesions.' That sentence gives a clinician something to verify against the images and reports. 'Had chemotherapy' gives them almost nothing.

The difference matters because the same label can hide opposite clinical stories. A patient who completed six cycles and had a documented partial response is in a different position from one who stopped after two cycles because the disease progressed. Both might write 'chemotherapy' on a form. Only the second version tells a treating team what the disease actually did, and that is the version that shapes what they ask next.

There is a second reason to describe results rather than names. A clinician reading your summary is trying to reconstruct a timeline: when the disease was found, what was done, and how it behaved afterwards. Treatment names fill in the middle of that timeline but leave the beginning and end blank. Results connect the timeline, so the reader can see whether the disease is stable, shrinking, or advancing, and can judge which earlier scans are worth re-reading.

This is also where a common misunderstanding appears. Sending a longer list of treatments does not make the picture clearer. A short list with outcomes is more useful than a long list without them. If you have ten treatments and no recorded response for any of them, the reader still cannot tell how the disease has behaved. If you have three treatments with dated results, they can.

So the practical rule is simple: never write a treatment without trying to write its result beside it. If the result is unknown, write that it is unknown and name the document that might contain it. That single habit turns a name list into a clinical history, and it is the part of your summary that a staging review can actually work with.

The four result elements to describe for each treatment

For each previous treatment, try to state four things. First, the treatment itself: the drug names or operation, the number of cycles or sessions, and the dates. Second, the intent: was it given before surgery, after surgery, as primary treatment, or for recurrent disease? Third, the response: what did the treating team record after treatment? Fourth, the evidence: which scan, pathology report or clinical note supports that response?

Response is often described in words rather than a single number. Phrases such as 'partial response', 'stable disease', 'progression', 'complete radiological response' or 'no evidence of disease' are meaningful, but they need the report that used them. If you do not have that report, say so rather than paraphrasing from memory.

If treatment was stopped early, say why. Toxicity, patient choice, progression and completion are different reasons, and each changes how a later team interprets the record. If the reason is not documented, write 'reason not documented in my records' instead of guessing.

  • Treatment name, regimen and dates
  • Intent: neoadjuvant, adjuvant, primary, or for recurrence
  • Recorded response after treatment
  • Supporting scan, pathology or clinical note

Imaging and pathology carry more weight than a summary letter

A staging review depends heavily on the original imaging and pathology. A summary letter written by a patient or family member is useful for orientation, but it is not a substitute for the dated radiology report, the actual images, and the pathology report. If a previous hospital will release images on disc or through a portal, that is usually more useful than a typed summary alone.

Pathology matters because it confirms the cancer type and may describe features that affect staging and treatment discussions. If a biopsy or surgical specimen was reviewed at more than one laboratory, include both reports and note which is most recent. Do not assume the newest report automatically supersedes an earlier one; the treating team needs to see the sequence.

Ask which existing studies can be reviewed and whether further investigations need to happen before treatment planning. That question belongs to the receiving clinical team, not to a coordination service. A records-based review can identify what is present and what is missing, but it does not assign a stage or confirm eligibility for any treatment.

How to write the treatment history section of your summary

Keep the treatment history in reverse chronological order, most recent first. Use one short block per treatment episode. Start with the dates, then the treatment, then the recorded result, then the source document. Avoid adjectives such as 'successful' or 'failed' unless a report uses that language, because those words carry clinical meaning that may not match the record.

A practical example of one block: 'January to April — four cycles of docetaxel and trastuzumab. Post-treatment PET-CT dated 12 May reported reduced uptake in the breast primary and no distant uptake. Source: PET-CT report and oncology clinic letter.' That is enough for a clinician to locate the evidence and form their own view.

If you are unsure whether a treatment was completed, write what you know and mark the uncertainty. 'Completed four of six planned cycles; reason for stopping not in my records' is more useful than a confident but incorrect statement. Clinicians can request clarification, but they cannot easily correct a summary that hides a gap.

What a staging review can and cannot settle

A staging review can organise the existing imaging, pathology and treatment history so that a treating team can see the disease course. It can highlight missing documents and questions that need answering. It cannot, by itself, assign a final stage, confirm that a particular treatment is suitable, or promise hospital acceptance.

Stage and grade are different concepts. Grade describes how abnormal the cancer cells look under a microscope; stage describes how far the disease has spread. Do not merge them in your summary. If a report uses a staging system you do not recognise, quote it exactly and let the clinician interpret it.

Not every cancer is staged with the same system, and some cancers are not staged in the same way at all. If you have been told a stage, include the system and the date it was assigned. If you have not, do not invent one. The absence of a stage is itself useful information for the review.

Preparing the enquiry and the next step

Start with a short summary rather than a complete archive. Include the diagnosis, the date of diagnosis, the treatments received with their recorded results, and your main question. After first contact, you can be guided on how to share the fuller records, including imaging and pathology reports.

Do not send passport numbers, card details or a complete medical archive in the first message. The initial enquiry is free and is used to check the available diagnosis, records and your main question, identify missing information, and suggest a relevant next step. It is not a diagnosis and not a promise of acceptance.

If you want to understand how a staging review is organised before you send anything, read the Cancer Staging Review reference page. It explains the review route without replacing the treating team's assessment.

A brief next step: prepare one page listing each treatment with its dates, recorded response and source document, then send that summary with your main question. The team can tell you what else is needed and whether a records-based opinion is worth arranging.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. National Cancer Institute: Cancer Staging

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.